28 August 2018

Interrad Medical, Inc.

LGB has acted as the European placement agent in the $7.5 million offering of secured convertible notes by Interrad Medical, Inc. (www.securacath.com). 

The company has developed a product platform for the stabilisation of catheters using a sub-cutaneous anchor. In 2H 2017 Interrad received $5.5 million in subscription to its issue of convertible notes. In 1H 2018 the company focussed on business developments, which included being selected for a central procurement contract with NHS England under its Innovation and Technology Payment Programme. More than 250 companies applied with Interrad and only four were successful. As a result of the company's progress, LGB has been able to arrange the issue of the remaining $2 million of notes.

Recent Articles

17 September 2018

LGB Corporate Finance appoints Andrew Hay as Chairman

LGB Corporate Finance is delighted to announce the appointment of Andrew Hay as Chairman. Read more

News & Insights

28 August 2018

Major Brewers are Coming for the Craft Beer Sector

Angus Grierson, Managing Director of LGB Corporate Finance, contributed to an article on major brewers’ increased investment in the craft beer sector.

Read more

News & Insights

28 August 2018

Interrad Medical, Inc.

LGB has acted as the European placement agent in the $7.5 million offering of secured convertible notes by Interrad Medical, Inc. Read more

News & Insights